A remote support program aims to make cannabis treatment easier to access
Telehealth-Plus-mHealth Intervention for Young Adults With Cannabis Use Disorder: Protocol for a Pilot Randomized Controlled Trial.
AI Summary
Cannabis use disorder (CUD) affects more than 5 million young adults in the United States, yet many do not receive care because of stigma, limited services, cost, time pressures, and low motivation. This paper describes MOMENT-V, a fully remote program combining two weekly telehealth sessions of motivational enhancement therapy with two weeks of mobile self-monitoring and personalized messages delivered after participants report triggers for cannabis use.
The study is a 2-arm pilot randomized controlled trial planned for 60 primary-care patients aged 18–26 who use cannabis at least three days per week and meet screening criteria for CUD. Participants will receive either MOMENT-V or enhanced usual care, with follow-up through six months. Because this is a study protocol, it reports no treatment results yet; its main purpose is to determine whether the intervention and trial are feasible, acceptable, and ready for a larger efficacy study. The findings could help clarify whether convenient digital support can reduce barriers to CUD treatment, but they will not yet show whether MOMENT-V reduces cannabis use or CUD symptoms.
💡 Key Findings
📄
Original Abstract
Related Research
Similar Studies
More Addiction research papers you might find interesting.
U.S. survey finds distinct patterns of frequent alcohol, nicotine, and…
Treatment records show a sharp rise in stimulant use in Oman, 2019–2024
An 18-month cohort found adverse outcomes were infrequent, but long-term risks…
Explore More Research
Stay informed about the latest cannabis science.